Medical and Research Laboratories Accomplishments

 

Invest NI, Government of Northern Ireland

Goal:   Support Invest Northern Ireland’s goal of stimulating Health and Life Sciences R&D investment across Northern Ireland by creating sustainable economic growth within the life sciences, which is a high-value market sector, and by promoting Foreign Direct Investment in the life sciences to achieve long-lasting job growth in Northern Ireland.

Result:

  • Assessed and ranked technology, business, commercialization, and market drivers related to 180 life science assets across nine thematic areas, with 30% related to IVD.
  • Identify, investigate, and facilitate partnerships between 32 assets and nearly 1000 international life science organizations.
  • Facilitated over 20 negotiations leading to 15 agreements with a near-term potential in excess of £6 MM.

 

The David H. Murdock Research Institute at the North Carolina Research Campus

Goal: To design and implement a non-invasive, multi-modal animal imaging facility within the institute.

Results:

  • Developed a strategy proposal that addressed the role of imaging in metabolic syndrome, the use of imaging to monitor the pharmacokinetics and pharmacodynamics of any pharmaceutical lead or candidate molecule, and the phased implementation of the facility and its associated capital and operating budget.
  • Worked with executive team to guide architects, engineers, and builders in the design and start-up of a non-invasive, multi-modal animal imaging facility.
  • Contacted well-regarded academic and industrial imaging facilities across the US to collate best practices associated with the design and operation of such a facility.
  • Performed a market assessment of the CRO imaging market to identify new imaging opportunities and their value.

 

The Bill and Melinda Gates Foundation

Goal: To improve TB disease management by monitoring TB drug resistance around the world and identifying new TB drug resistant strains.

Results:

  • Designed a core laboratory to monitor TB drug resistance and to focus specifically on surveillance. This laboratory has the capability to perform several genetic analysis protocols on patient samples to accurately and cost-effectively catalog the number and distribution of mutations associated with drug resistance and to help identify new genetic strains.
  • The core lab design enabled the use of automated instrumentation and associated software to perform the following tasks:
    • Collect Acid Fast Bacillus-stained sputum microscope slide smears (AFB smears)
    • Extract and preserve biological material from AFB smears
    • Store and retrieve the biological samples
    • Genetically analyze samples
    • Analyze, report, and track the data

     

    Impinj

    Goal: Our client was looking to expand their Ultra High Frequency Radio Frequency Identification Device (UHF RFID) business from packaging into the life sciences business sector.

    Results:

  • Identified opportunities for expansion into the life sciences based on the company’s existing core competencies as well as realistic growth of R&D capabilities over the following five years.
  • Prioritized these opportunities against development and validation criteria, market size, and barriers to entry.
  • Established and facilitated strategic discussions with industry leaders for the top opportunities and help close one of these relationships.